|
1
|
Nair VS, Pritchard CC, Tewari M and
Ioannidis JP: Design and analysis for studying microRNAs in human
disease: A primer on -omic technologies. Am J Epidemiol.
180:140–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arora S, Swaminathan SK, Kirtane A,
Srivastava SK, Bhardwaj A, Singh S, Panyam J and Singh AP:
Synthesis, characterization and evaluation of poly
(D,L-lactide-co-glycolide-based nanoformulation of miRNA-150:
Potential implications for pancreatic cancer therapy. Int J
Nanomedicine. 9:2933–2942. 2014.PubMed/NCBI
|
|
3
|
Chen WX, Cai YQ, Lv MM, Chen L, Zhong SL,
Ma TF, Zhao JH and Tang JH: Exosomes from docetaxel-resistant
breast cancer cells alter chemosensitivity by delivering microRNAs.
Tumour Biol. 35:9649–9659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo J, Liu X and Wang M: miR-503
suppresses tumor cell proliferation and metastasis by directly
targeting RNF31 in prostate cancer. Biochem Biophys Res Commun.
64:1302–3028. 2015. View Article : Google Scholar
|
|
5
|
Li B, Liu L, Li X and Wu L: miR-503
suppresses metastasis of hepatocellular carcinoma cell by targeting
PRMT1. Biochem Biophys Res Commun. 64:982–987. 2015. View Article : Google Scholar
|
|
6
|
Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin
LR: MicroRNA-503 suppresses proliferation and cell-cycle
progression of endometrioid endometrial cancer by negatively
regulating cyclin D1. FEBS J. 280:3768–3779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH,
Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res (Phila).
5:665–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou J, Tao Y, Peng C, Gu P and Wang W:
miR-503 regulates metastatic function through Rho guanine
nucleotide exchanger factor 19 in hepatocellular carcinoma. J Surg
Res. 188:129–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao F, Zhang W, Chen L, Chen F, Xie H,
Xing C, Yu X, Ding S, Chen K, Guo H, et al: MicroRNA-503 inhibits
the G1/S transition by downregulating cyclin D3 and E2F3 in
hepatocellular carcinoma. J Transl Med. 11:1952013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukui T, Fukumoto K, Okasaka T, Kawaguchi
K, Nakamura S, Hakiri S, Ozeki N, Hirakawa A, Tateyama H and Yokoi
K: Clinical evaluation of a new tumour-node-metastasis staging
system for thymic malignancies proposed by the International
Association for the Study of Lung Cancer Staging and Prognostic
Factors Committee and the International Thymic Malignancy Interest
Group. Eur J Cardiothorac Surg: Nov. 7:2015.(Epub ahead of
print).
|
|
11
|
Yang Y, Liu L, Zhang Y, Guan H, Wu J, Zhu
X, Yuan J and Li M: MiR-503 targets PI3K p85 and IKK-β and
suppresses progression of non-small cell lung cancer. Int J Cancer.
135:1531–1542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou L, Wu SW, Yu L, Song WQ, Cheng ZN and
Wang DN: The expression of KAI1 in gastric adenocarcinoma and
relationship with angiogenesis/lymphangiogenesis. Sichuan Da Xue
Xue Bao Yi Xue Ban. 45:43–48. 2014.(In Chinese). PubMed/NCBI
|
|
13
|
Liu X, Guo XZ, Li HY, Chen J, Ren LN and
Wu CY: KAI1 inhibits lymphangiogenesis and lymphatic metastasis of
pancreatic cancer in vivo. Hepatobiliary Pancreat Dis Int.
13:87–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiu B, Lin Y, Grote DM, Ziesmer SC,
Gustafson MP, Maas ML, Zhang Z, Dietz AB, Porrata LF, Novak AJ, et
al: IL-10 induces the development of immunosuppressive
CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Blood Cancer J. 5:e3282015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hua Q, Zhu Y and Liu H: Severe and fatal
adverse events risk associated with rituximab addition to B-cell
non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis. J
Chemother. 2015.Apr 15: 1973947815Y0000000025. [Epub ahead of
print]. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghorbian S, Jahanzad I, Javadi GR and
Sakhinia E: Evaluation diagnostic usefulness of immunoglobulin
light chains (Igκ, Igλ) and incomplete IGH D-J clonal gene
rearrangements in patients with B-cell non-Hodgkin lymphomas using
BIOMED-2 protocol. Clin Transl Oncol. 16:1006–1011. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scwab M: Ann Arbor Staging System.
Encyclopedia of Cancer (2nd). (Berlin, Heidelberg). Springer Berlin
Heidelberg. 169. 2009. View Article : Google Scholar
|
|
18
|
Swerdlow SH, Campo E, Harris NL, et al:
WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues. 2:(4th). Lyon, France: IARC Press. 2008.
|
|
19
|
Yamashita Y, Hasegawa M, Deng Z, Maeda H,
Kondo S, Kyuna A, Matayoshi S, Agena S, Uehara T, Kouzaki H, et al:
Human papillomavirus infection and immunohistochemical expression
of cell cycle proteins pRb, p53, and p16(INK4a) in sinonasal
diseases. Infect Agent Cancer. 10:232015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You J, Madigan MC, Rowe A, Sajinovic M,
Russell PJ and Jackson P: An inverse relationship between KAI1
expression, invasive ability, and MMP-2 expression and activity in
bladder cancer cell lines. Urol Oncol. 30:502–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Altman T, Travers M, Kothari A, Caspi R
and Karp PD: A systematic comparison of the MetaCyc and KEGG
pathway databases. BMC Bioinformatics. 14:1122013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sekimzu M, Mori T, Kikuchi A, Mitsui T,
Sunami S, Kobayashi R, Fujita N, Inada H, Takimoto T, Saito AM, et
al: Prognostic impact of cytogenetic abnormalities in children and
adolescents with mature B-cell non-Hodgkin lymphoma: A report from
the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Pediatr Blood Cancer. 62:1294–1296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bruni R, Marcantonio C, Pulsoni A, Tataseo
P, De Angelis F, Spada E, Marcucci F, Panfilio S, Bianco P,
Riminucci M, et al: microRNA levels in paraffin-embedded indolent
B-cell non-Hodgkin lymphoma tissues from patients chronically
infected with hepatitis B or C virus. BMC Infect Dis 14 Suppl.
5:S62014. View Article : Google Scholar
|
|
24
|
Song A, Ye J, Zhang K, Yu H, Gao Y, Wang
H, Sun L, Xing X, Yang K and Zhao M: Aberrant expression of the
CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma.
Leuk Res. 39:536–543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang K, Jiang Y, Zheng W, Liu Z, Li H, Lou
J, Gu M and Wang X: Silencing of Human
Phosphatidylethanolamine-Binding Protein 4 Enhances
Rituximab-Induced Death and Chemosensitization in B-Cell Lymphoma.
PLoS One. 8:e568292013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Di Lisio L, Sánchez-Beato M, Gómez-López
G, Rodríguez ME, Montes-Moreno S, Mollejo M, Menárguez J, Martínez
MA, Alves FJ, Pisano DG, et al: MicroRNA signatures in B-cell
lymphomas. Blood Cancer J. 2:e572012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tagawa H, Ikeda S and Sawada K: Role of
microRNA in the pathogenesis of malignant lymphoma. Cancer Sci.
104:801–809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
microRNA-503 inhibits gastric cancer cell growth and
epithelial-to-mesenchymal transition. Oncol Lett. 7:1233–1238.
2014.PubMed/NCBI
|
|
29
|
Maurer CA, Graber HU, Friess H, Beyermann
B, Willi D, Netzer P, Zimmermann A and Büchler MW: Reduced
expression of the metastasis suppressor gene KAI1 in advanced colon
cancer and its metastases. Surgery. 126:869–880. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo X, Friess H, Graber HU, Kashiwagi M,
Zimmermann A, Korc M and Büchler MW: KAI1 expression is
up-regulated in early pancreatic cancer and decreased in the
presence of metastases. Cancer Res. 56:4876–4880. 1996.PubMed/NCBI
|
|
31
|
Yang JL, Jackson P, Yu Y, Russell PJ,
Markovic B and Crowe PJ: Expression of the KAI1 metastasis
suppressor gene in non-metastatic vs. metastatic human colorectal
cancer. Anticancer Res. 22:3337–3342. 2002.PubMed/NCBI
|
